The Valens Company Inc. VLNS.TO TSX

Toronto Stock Exchan • Healthcare • Drug Manufacturers - Specialty & Generic • CA • CAD

SharesGrow Score

30/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

The Valens Company Inc. (VLNS.TO) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 28/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

30/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

健康

67/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

14/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — VLNS.TO

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.55

EV/EBITDA0.0

每股数据

EPS (TTM)$-1.15

每股账面价值$0.00

每股营收$1.84

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2011	$-0.36	$0.00	$-86.05K	-
2012	$-4.25	$0.00	$-1.72M	-
2013	$-2.32	$0.00	$-1.45M	-
2015	$-0.37	$132.52K	$-591.8K	-446.6%
2016	$-0.49	$105K	$-8.33M	-7935.8%
2017	$-0.25	$40.72K	$-4.63M	-11359.6%
2018	$-0.65	$51.53K	$-15.91M	-30881.1%
2019	$-0.18	$58.11M	$-6.54M	-11.2%
2020	$-0.49	$83.78M	$-20.68M	-24.7%
2021	$-1.15	$78.18M	$-49.03M	-62.7%